This video contains adult content. To view this video you must be 18+.
Click here to disable the family filter. You can also disable the family filter in the user options (Recommend because this will disable the filter when you are log in).
Turing
Pharmaceuticals
CEO Martin Shkreli
defended raising
the price of
Daraprim from
$13.50 to $750,
even though it is
used to treat
vulnerable group
(more)
Turing Pharmaceuticals CEO Martin Shkreli defended raising the price of Daraprim from $13.50 to $750, even though it is used to treat vulnerable groups like AIDS and cancer patients. “This particular drug is used by a small but vulnerable group of patients,†Dahler pointed out to Shkreli. “So you see how greedy this move looks.†Posted By Persist